We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Baxter Divests Dialysis Businesses

By HospiMedica staff writers
Posted on 21 Jul 2003
Print article
The divestiture of some renal therapy services (RTS) dialysis centers outside the United States and agreements to sell the company's US-based renal management Lifeline access management and disease management businesses has been announced by Baxter Healthcare Corp. (Deerfield, IL, USA).

Avitum Austria GmbH, a subsidiary of B. Braun (Melsungen, Germany), will acquire four renal care centers in Slovakia and the Czech Republic. Atvium will continue to work with Baxter to provide dialysis services in those countries. DaVita, Inc. (Torrance, CA, USA), will acquire the US-based Lifeline access and disease management businesses. Lifeline manages vascular access centers to meet the needs of end-stage renal disease (ESRD) patients.

"The sale of these service businesses allows Baxter to concentrate on our core products to improve renal care,” said Al Heller, senior vice president of Baxter. "In addition, these transactions provide us with the opportunity to continue building product sales based on our relationships with the buyers of these businesses.” In April 2003, Baxter completed the sale of its dialysis centers in Italy to a management group that had been operating them under contract. Baxter is currently analyzing offers for the remaining dialysis centers.




Related Links:
Baxter
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Digital Pump
Theia
New
Digital Radiography System
DigiEye 680

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.